Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY19 is not expected to be complete until June, 2020.

  1. DEVELOPMENT OF NEW ANTI-FELINE LEUKEMIA VIRUS DRUGS

    SBC: ALBUQUERQUE AVIAN EXOTIC            Topic: N/A

    IN COLLABORATIVE STUDIES WITH THE UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE, WE HAVE OBTAINED PRELIMINARY DATA ON THE ANTIVIRAL PROPERTIES OF DERIVATIVES OF THE NATURAL PRODUCT GOSSYPOL. IN PARTICULAR, ONE DERIVATIVE NAMED GIL HAS SHOW PROMISING ACTIVITY IN THE TREATMENTOF DOMESTIC CATS INFECTED WITH FELINE LEUKEMIA VIRUS (FELV). ALSO NOTEWORTHY IS THE FACT THAT GIL SHOWS PROMISING IN VITRO ACTI ...

    SBIR Phase I 1992 Department of Health and Human Services
  2. TRAINING SECONDARY PREVENTION OF FETAL ALCOHOL SYNDROME

    SBC: Alcohol Self-control Program            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  3. SILENT PUMP FOR LASER SMOKE REMOVAL AND STERILIZATION

    SBC: Ballena Systems Corp            Topic: N/A

    A SMOKE EVACUATION SYSTEM IS AN ESSENTIAL PART OF LASER SURGERY, BOTH IN RESEARCH AS WELL AS IN HUMAN SURGERY. CURRENT TECHNIQUES FOR THE REMOVAL OF SMOKE AND DEBRIS GENERATED DURING LASER SURGERY ARE INEFFICIENT, NOISY, AND EXPOSE THE SURGEONS AND SUPPORT PERSONNEL TO THE HAZARDS OF PATHOLOGICAL AIRBORNE AEROSOLS. THE AIRBORNE AEROSOLS ARE CURRENTLY REMOVED THROUGH VACUUM ACTION (AIR PUMPS) AND C ...

    SBIR Phase I 1992 Department of Health and Human Services
  4. Semi Automated Integrated System for Single Cell Sorting

    SBC: Cell Robotics, Inc.            Topic: N/A

    The capability to routinely sort single cells with absolute purity will be developed. This applicatneeds scientists of the cancer research community have to easily select and isolate unique cells, suspecific cloning or abnormal cells, for genetic analysis. A new apparatus will be developed and desithese application requirements. It will give scientists access to cutting edge technologies and unprs ...

    SBIR Phase II 1997 Department of Health and Human Services
  5. LASER INSTRUMENT FOR IN VITRO PHOTOTHERMAL ABLATION

    SBC: Cell Robotics, Inc.            Topic: N/A

    DESCRIPTION: (Adapted from the Applicant's Abstract). It is proposed to develop an IR pulsed laser ablation system for assisted (IVF). The ablation will be used to ablate the zona pellucida (ZP) to assist embryo hatching from the ZP to facilitate reimplantation. A wavelength has been selected (1480nm) that will allow the light to be delivered through a microscope objective, the bottom of the cu ...

    SBIR Phase I 1997 Department of Health and Human Services
  6. DIAGNOSING DEPRESSION IN PRIMARY CARE--A MULTIMEDIA TOOL

    SBC: Computer One, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  7. MULTISPECTRAL FUNDUS IMAGING SYSTEM

    SBC: Kestrel Corporation            Topic: N/A

    N/A

    SBIR Phase I 1997 Department of Health and Human Services
  8. DIRECT RADIOMETAL LABELING FOR IMAGING AND THERAPY

    SBC: Rhomed, Inc.            Topic: N/A

    ANTIBODIES OR ANTIBODY FRAGMENTS, REDUCED AND LYOPHILIZED FOR USE IN PREPARING INSTANT, ONE-STEP TC-99M RADIOPHARMACEUTICALS, CAN ALSO BE LABELED WITH CU-67. THE CU-67, AS CU(II) IN A PH 5.6 BUFFER, IS SIMPLY ADDED TO THE ANTIBODY TO GENERATE THE CU-67-LABELED ANTIBODY. THE PURPOSE OF THIS PROJECT IS TO DETERMINE THE PARAMETERS OF THIS REACTION AND THE PURITY, STABILITY, AND IMMUNO-REACTIVITY OF T ...

    SBIR Phase I 1992 Department of Health and Human Services
  9. OPPORTUNISTIC INFECTION IMAGING IN AIDS

    SBC: Rhomed, Inc.            Topic: N/A

    OPPORTUNISTIC INFECTIONS ARE A MAJOR CAUSE OF MORBIDITY AND MORTALITY IN AIDS PATIENTS. ALTHOUGH IT IS GENERALLY BELIEVED THAT THE EARLY DIAGNOSIS AND TREATMENT OF AN OPPORTUNISTIC INFECTION IS CRITICAL TO DECREASING MORBIDITY AND INCREASING OVERALL SURVIVAL, LOCALIZING THE SITE OF THESE INFECTIONS IS OFTEN DIFFICULT. CURRENTLY, THERE ARE TWO ACCEPTED TECHNIQUES FOR WHOLE-BODY EVALUATION USING RAD ...

    SBIR Phase I 1992 Department of Health and Human Services
  10. TC-99M-LABELED CHEMOTACTIC PEPTIDES FOR ABSCESS IMAGING

    SBC: Rhomed, Inc.            Topic: N/A

    FORMULATED CHEMOTACTIC PEPTIDES, WITH ENDOGENOUS TC-99M BINDING SITES, WILL BE DEVELOPED FOR USE IN LOCALIZING ABSCESSES, INFLAMMATIONS, AND INFECTIONS. THE PEPTIDES ARE DESIGNED TO HAVE THE BIOLOGICAL FUNCTION LOCATED AT ONE END OF THE MOLECULE, AND THE TC-99M BINDING SITE AT THE OTHER END OF THE MOLECULE. IN PHASE I THE CHEMOTACTIC PEPTIDE ANALOGS WILL BE FORMULATED IN SINGLE-STEP, DIRECT LABELI ...

    SBIR Phase I 1992 Department of Health and Human Services
US Flag An Official Website of the United States Government